YETI:NYSEYETI Holdings, Inc. Analysis
Data as of 2026-05-12 - not real-time
$40.92
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
YETI trades around $40.9, roughly double the DCF‑derived fair value of $20.9, indicating the market is pricing significant growth expectations into the stock. YETI posted $1.87 B in revenue with 6.8% YoY growth, confirming top‑line momentum. Operating margin of 12.7% and free cash flow of $90.6 M demonstrate solid profitability. A forward PE of 12.6 versus trailing PE of 20.2 underscores expected earnings acceleration. The balance sheet shows modest net debt (debt‑to‑equity 35%) and ample cash, keeping financial risk low. Analyst consensus of 15 “Buy” recommendations and a median price target of $53 imply upside of roughly 23% from current levels.
Technically, the 20‑day SMA ($40.10) sits just below price, while the 50‑day SMA ($38.71) remains supportive, indicating a neutral to slightly bullish bias. MACD is bullish with the line above the signal, and the histogram is positive. RSI at 55 suggests the stock is not overbought. Volume trend is decreasing, which could limit short‑term momentum. Beta of 1.7 and 30‑day volatility of 46% point to heightened price swings. Combined with an “Extreme Greed” market sentiment, the stock appears positioned for a breakout but with notable risk.
Technically, the 20‑day SMA ($40.10) sits just below price, while the 50‑day SMA ($38.71) remains supportive, indicating a neutral to slightly bullish bias. MACD is bullish with the line above the signal, and the histogram is positive. RSI at 55 suggests the stock is not overbought. Volume trend is decreasing, which could limit short‑term momentum. Beta of 1.7 and 30‑day volatility of 46% point to heightened price swings. Combined with an “Extreme Greed” market sentiment, the stock appears positioned for a breakout but with notable risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and neutral RSI
- Decreasing volume limiting momentum
- High beta and volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus buy and 23% upside target
- Strong revenue growth and improving margins
- Robust free cash flow generation
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Brand strength and premium positioning
- Valuation gap between price and DCF fair value
- Sustainable cash flow and manageable debt
Key Metrics & Analysis
Financial Health
Revenue Growth6.80%
Profit Margin8.85%
P/E Ratio20.2
ROE23.79%
ROA10.59%
Debt/Equity35.13
P/B Ratio4.7
Op. Cash Flow$254.7M
Free Cash Flow$90.6M
Technical Analysis
TrendNeutral
RSI54.7
Support$36.91
Resistance$43.54
MA 20$40.10
MA 50$38.71
MA 200$39.50
MACDBullish
VolumeDecreasing
Fear & Greed Index88.61
Valuation
Fair Value$20.88
Target Price$50.47
Upside/Downside23.33%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.74
Volatility46.51%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.